Cross-sectional and longitudinal studies suggest pharmacological treatment used in patients with glucokinase mutations does not alter glycaemia

Diabetologia

Volumn 57, Issue 1, 2014, Pages 54-56

  Stride, Amanda ^a   Shields, Beverley ^b   Gill Carey, Olivia ^b   Chakera, Ali J ^b   Colclough, Kevin ^a   Ellard, Sian ^a,b   Hattersley, Andrew T ^a,b  

^a ROYAL DEVON AND EXETER NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF EXETER MEDICAL SCHOOL   (United Kingdom)

Author keywords

GCK mutation; Glucokinase; MODY; Pharmacogenetics; Treatment

Indexed keywords

GLIBENCLAMIDE; GLUCOKINASE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; METFORMIN; ORAL ANTIDIABETIC AGENT;

ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FOLLOW UP; GENE MUTATION; GENETIC SCREENING; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HETEROZYGOTE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT REFERRAL; PHARMACOGENETICS; PRIORITY JOURNAL; TREATMENT DURATION; TREATMENT OUTCOME;

BLOOD GLUCOSE; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; GLUCOKINASE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; LONGITUDINAL STUDIES; MUTATION;

EID: 84890900649     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-013-3075-x     Document Type: Article

References (9)

1. Hattersley AT, Turner RC, Permutt MA et al (1992) Linkage of type 2 diabetes to the glucokinase gene. Lancet 339:1307-1310
2. Stride A, Vaxillaire M, Tuomi T et al (2002) The genetic abnormality in the beta cell determines the response to an oral glucose load. Diabetologia 45:427-435
3. Byrne MM, Sturis J, Clement K et al (1994) Insulin secretory abnormalities in subjects with hyperglycemia due to glucokinase mutations. J Clin Invest 93:1120-1130
4. Feigerlova E, Pruhova S, Dittertova L et al (2006) Aetiological heterogeneity of asymptomatic hyperglycaemia in children and adolescents. Eur J Pediatr 165:446-452
5. 1c in the identification of patients with hyperglycaemia caused by a glucokinase mutation: observational case control studies. PLoS One 8:e65326
6. Velho G, Vaxillaire M, Boccio V, Charpentier G, Froguel P (1996) Diabetes complications in NIDDM kindreds linked to the MODY3 locus on chromosome 12q. Diabetes Care 19:915-919
7. Spyer G, Macleod KM, Shepherd M, Ellard S, Hattersley AT (2009) Pregnancy outcome in patients with raised blood glucose due to a heterozygous glucokinase gene mutation. Diabet Med 26:14-18
8. Pearson ER, Flechtner I, Njolstad PR et al (2006) Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations. N Engl J Med 355:467-477
9. Pearson ER, Starkey BJ, Powell RJ, Gribble FM, Clark PM, Hattersley AT (2003) Genetic cause of hyperglycaemia and response to treatment in diabetes. Lancet 362:1275-1281